Stay updated on Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page has been updated with new dates for clinical trial milestones and revisions to the informed consent form, indicating a shift in the timeline and documentation related to the study.SummaryDifference0.5%
- Check13 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.4%
- Check20 days agoChange DetectedThe page has updated the name of the medical center to 'MaineHealth Maine Medical Center- Scarborough' and has revised the version number to v2.16.0.SummaryDifference0.2%
- Check51 days agoChange DetectedThe webpage has been updated to include new clinical trial identifiers, additional cancer types, and a revised timeline for patient treatment assignments, while removing extensive details about the trial's objectives and treatment protocols.SummaryDifference31%
- Check62 days agoChange DetectedThe webpage has been updated to include new results and metrics related to cancer treatment outcomes, such as progression-free survival (PFS), overall survival (OS), and quality of life (QoL) assessments, while removing outdated information and previous result dates.SummaryDifference13%
- Check174 days agoChange DetectedDifference0.4%
Stay in the know with updates to Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page.